A systematic review of digital technology and innovation and its potential to address anti-corruption, transparency, and accountability in the pharmaceutical supply chain-Reference-Cited by-同舟云学术

A systematic review of digital technology and innovation and its potential to address anti-corruption, transparency, and accountability in the pharmaceutical supply chain

Published:2022-06-28 Issue:8 Volume:21 Page:1061-1088
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Saeed Gul¹,Kohler Jillian C.¹²^ORCID,Cuomo Raphael E.³⁴^ORCID,Mackey Tim K¹³⁵^ORCID

Affiliation:

1. Accountability and Transparency in the Pharmaceutical Sector, WHO Collaborating Centre for Governance, Toronto, ON, Canada

2. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada

3. Global Health Policy and Data Institute, San Diego, CA, USA

4. Department of Anesthesiology, University of California, San Diego – School of Medicine, La Jolla, CA, USA

5. Global Health Program, Department of Anthropology, University of California, San Diego, La Jolla, CA, USA

Funder

Connaught Global Challenge Award

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2022.2091543

Reference111 articles.

1. Transparency International. What is Corruption? [Internet]. Transparency International. 2018 [cited 2021 August 4]. Available from: https://www.transparency.org/what-is-corruption

2. Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines

3. Guterres A. Statement on corruption in the context of COVID-19. [Internet]. United Nations. 2020 [2021August 4]. Available from: https://www.un.org/en/coronavirus/statement-corruption-context-covid-19

4. UNDOC. Covid-19 Vaccines and Corruption Risks: Preventing Corruption in the Manufacture, Allocation and Distribution of Vaccines. Place Unknown: UNODC; 2020. [cited 2021 August 3]. Available from: https://www.unodc.org/documents/corruption/COVID-19/Policy_paper_on_COVID-19_vaccines_and_corruption_risks.pdf

5. The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 Pandemic

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to blockchain-enabled drug recycling: A TISM-MICMAC approach;Sustainable Chemistry and Pharmacy;2024-10

2. Healthcare procurement in the race to net-zero: Practical steps for healthcare leadership;Healthcare Management Forum;2024-07-21

3. Untangling the corruption maze: exploring the complexity of corruption in the health sector;Health Economics Review;2024-07-12

4. Examining the white and dark sides of digitalisation effects on corruption: unveiling research patterns and insights for future research;The Journal of Risk Finance;2024-01-04

5. Promoting transparency and accountability towards anti-corruption in pharmaceutical procurement system: does e-procurement play a significant role?;Management Matters;2024-01-03